Gleevec does not cross blood-brain barrier

Lancet Oncol. 2003 Apr;4(4):198. doi: 10.1016/s1470-2045(03)01050-7.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacokinetics*
  • Benzamides
  • Blood-Brain Barrier*
  • Humans
  • Imatinib Mesylate
  • Mice
  • Piperazines / pharmacokinetics*
  • Protein-Tyrosine Kinases / analysis
  • Pyrimidines / pharmacokinetics*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases